Can you diagnose this patient?
News

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the January/February, 2025, issue of Contemporary Pediatrics.

Nurse practitioner Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN underscores how critical simple, but factual, conversations can be with parents when it comes to pediatric care.

A study found that 2 weeks of maternal bed rest significantly increases fetal weight and growth metrics in small for gestational age fetuses.

The patient had increased her vape use recently, but did not disclose when she started, or how much she vaped.

Swedish study highlights challenges in managing pain for preterm infants, revealing disparities in pain treatment and assessment across neonatal care.

From 1999 to 2022, a 24.2% decrease in infant mortality was observed in the US, however, SUID mortality rates increased by nearly 12% from 2020 to 2022.

The higher dose regimen of nusinersen comprises a more rapid loading regimen, two 50 mg doses 14 days apart, and higher maintenance regimen, 28 mg, every 4 months.

Based on recent reports, norovirus outbreaks in the 2024-2025 seasonal year is above the range reported from the 2012-2020 and 2021-2024 seasonal years.

Already approved in those aged 18 and older in the United States, Valneva has submitted label extension applications to the FDA for IXCHIQ use in adolescents aged 12 to 17 years.

Detectable TTE in children's urine were 'significantly higher' in homes with reported in-home cannabis smoking.

During the current cold and flu season, children have a higher risk of getting sick. The AAP has release tips and reminders for parents to help keep children comfortable and healthy.

Eligible schools have the opportunity to receive 2 cartons of epinephrine nasal spray for use in emergency situations to treat type I allergic reactions, including anaphylaxis.

"In aggregation with other robust observational studies, these results can inform the management of asthma and allergic rhinitis in this patient group," wrote the study authors.

"The greatest risk reductions were demonstrated in those who experienced obesity remission during childhood," stated study authors.

Robert Frenck, MD, offers several practical tips to use when discussing pediatric vaccination among vaccine-hesitant parents.

Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial, and explains the role the pediatrician can play in care and recruitment.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Susan Carnell, PhD, highlights the nuanced relationship between social media use and binge eating in adolescents, noting the importance of addressing addictive behaviors and seeking support when needed.

HHS selects 15 more Medicare Part D drugs for price negotiation under the Inflation Reduction Act, aiming to lower costs for millions by 2027.

Read these quick comments from Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, and Bernard Cohen, MD, regarding the banning of red No. 3 from foods and ingested drugs.

The digestive enzyme cartridge is designed to mimic pancreatic lipase function.

A CDC report shows only 23% of U.S. teens get enough sleep, with disparities highlighting the need for targeted health interventions.

Across all years in the report, the CDC rated each physical activity trend with a color of red, indicating that trends are going in the "wrong direction."

Manufacturers who use red no. 3 in food and and ingested drugs will have until January 15, 2027 or January 18, 2028, respectively, to reformulate their products.

The lead clinical trial investigator for a phase 3 study of crinecerfont in pediatric CAH patients breaks down the December 2024 FDA approval.

Of those with a minimum age or minimum interval vaccine dose, 44.9% ended up receiving extra doses to complete a vaccination series.

Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial assessing mono vs dual therapy for pediatric PAH.

Neffy was first approved in September 2024 to treat type 1 allergic reactions in patients who weigh at least 66 lbs (33 kg).

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

